Developing Oligonucleotides Into Therapies: Opportunities and Challenges

July 6, 2023
Shalini Andersson, PhD

Post Views: 2,197

Webinars

Bioanalysis of Oligonucleotide Therapeutics via Nucleic Acid Nanorobotic Platform

Immunogenicity Risk Assessment for Nucleic Acid Therapeutics

Trainee Spotlight Series: 2025 Oligo Meeting Poster Winners 6

Advancing Precision Medicine: Oligonucleotide Therapeutics and Genome Editing

SHARE

OTS-Event_9_

Time: 8AM PST / 11AM EST / 5PM CET
Date: July 6, 2023

Speakers:

Shalini

Shalini Andersson, PhD
Vice President of Oligonucleotide Discovery
AstraZeneca

Subscribe to our Newsletter

Oligonucleotide Therapeutics Society

Oligonucleotide Therapeutics Society

3960 W Point Loma Blvd, Suite H
Box 346
San Diego, CA 92110

info@oligotherapeutics.org

Terms & Conditions

Resources

Subscribe in a reader

Stay Connected

Search

© Copyright 2012 – 2026 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Enter Username or Email Address:
Password:
Forgot Password? | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone: *
Organization Name
Select Sectors

Reload
Already have an account? Login